NCT00005649View on ClinicalTrials.gov

Paclitaxel and Capecitabine in Treating Women With Metastatic Breast Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

July 31, 1998

Primary Completion Date

July 4, 2002

Study Completion Date

July 4, 2002

Conditions
Breast Cancer
Interventions
DRUG

capecitabine

DRUG

paclitaxel

Trial Locations (1)

28412

PPD Development, Wilmington

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT00005649 - Paclitaxel and Capecitabine in Treating Women With Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter